We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pharma Cos. Will Open Abandoned Drugs To Outside Research

Law360, New York (May 3, 2012, 3:10 PM EDT) -- Three major pharmaceutical companies will allow outside scientists to examine potential drug compounds that the companies began developing but abandoned, in the hopes that the scientists will come up with new marketable therapies, under a new government-funded program announced Thursday.

The companies, Pfizer Inc., AstraZeneca PLC and Eli Lilly & Co., will give researchers access to up to 24 chemical compounds and their related scientific data, which the companies spent years developing and had to shelve either for business reasons or because the compounds turned out...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.